Streamlined Data Collection

Slides:



Advertisements
Similar presentations
Research Study Regulatory Binder Ronald Cowan, MD, PhD J. Gavin Lillevig, BS Summer Professional Didactics Data Management Psychiatric Neuroimaging Program.
Advertisements

A Blueprint For Clinical Research: Standard Operating Procedures
ICTR The Johns Hopkins Institute for Clinical and Translational Research Preparing for ClinicalTrials.gov Results Reporting and Module 2: Baseline Characteristics.
How does the process work? Submissions in 2007 (n=13,043) Perspectives.
HIBBs is a program of the Global Health Informatics Partnership Introduction to Form Design Regional East African Centre for Health Informatics (REACH-INFORMATICS)
Unit 4: Monitoring Data Quality For HIV Case Surveillance Systems #6-0-1.
An introduction to CDISC and CDASH Bring on the Standards! Emmanuelle Denis M.Sc., MICR Global Health Clinical Trials Research Programme.
Accredited Member of the Association of Clinical Research Professionals, USA Tips on clinical trials Maha Al-Farhan B.Sc, M.Phil., M.B.A., D.I.C.
Introduction to Clinical Protocol
ACRIN 6698 Diffusion-weighted MRI Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: An I-SPY 2 Trial Substudy Presented by:
© 2011 Octagon Research Solutions, Inc. All Rights Reserved. The contents of this document are confidential and proprietary to Octagon Research Solutions,
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
MODULE B: Case Report Forms Jane Fendl & Denise Thwing April 7, Version: Final 07-Apr-2010.
September, 2010 at SMMU, Shanghai
Module 5: Data Collection. This training session contains information regarding: Audit Cycle Begins Audit Cycle Begins Questionnaire Administration Questionnaire.
Introduction to the Statistical Analysis of the Clinical Trials
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
Identifying and recruiting patients for clinical trials in the future: a pharma perspective Rob Thwaites EC/EFPIA Workshop on ” Primary and secondary use.
Investigational Devices and Humanitarian Use Devices June 2007.
Education Performance Measures Session. Session Overview Combination of presentation and interactive components Time at the end of the session for Q&A.
The Quality Improvement Project MODULE 4: A FRAMEWORK FOR QI: THE MODEL FOR IMPROVEMENT October 2015.
UNIT-II CLINICAL DATA. UNIT-II CLINICAL DATA: Clinical Data, Application, Challenges, Solutions, Clinical Data Management System.
24 Nov 2007Data Management and Exploratory Data Analysis 1 Yongyuth Chaiyapong Ph.D. (Mathematical Statistics) Department of Statistics Faculty of Science.
Medidata Rave Start-Up Information
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Briefing on MHRA routine inspection of non-commercial clinical trials
Design of Case Report Forms
A FRUIT AND VEGETABLE PRESCRIPTION PROGRAM
The Role and Responsibilities of the Clinical Research Coordinator
Observational Study Working Group
Responsibilities of Sponsor, Investigator and Monitor
CONDUCTING THE TRIAL AT
Clinicaltrials.gov Update
5. National and international reporting of adverse events: mechanisms, routes and resources Multi-partner training package on active TB drug safety monitoring.
Investigator of Record – Definition
CLINICAL PROTOCOL DEVELOPMENT
What is a Data and Safety Monitoring Plan and how do I get one?
Reasonable Assurance of Safety and Effectiveness: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division.
HOW TO CONSENT A PATIENT?
HIV Drug Resistance Training
Reasons for Auditing There are many reasons for auditing. Some examples of these reasons might be: Requested by the IRB Committee Requested by an IRB.
Data Managers’ Forum What’s in it for us?
Protocol References Section Title 6.2 Entry Visit 5.1
Methodology Part 1 Research Design and Analysis
Protocol References Section Title 6.2 Entry Visit 5.1
Clinical Study Results Publication
Medical Device Regulatory Essentials: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Overview of the FEPAC Accreditation Process
Air Carrier Continuing Analysis and Surveillance System (CASS)
Six Sigma Green Belt Training
2018 NM Community Survey Data Entry Training
Quality Control SOP 3.12 Release Date: 08/10/2015.
Investigator of Record – Definition
Investigator of Record – Definition
Cindy Murray NP Princess Margaret Cancer Centre
Welcome to eHEPQUAL.
Screening Epoch Disposition eCRF
How To conduct a thesis 1- Define the problem
Module 4 Part 3 Operationalizing the Measures
DESIGN OF CRF CRF.
How To conduct a thesis 1- Define the problem
Discrepancy Management
CREDO 0verview & workshop objectives
DESIGN OF CRF CRF.
Quality Assurance in Clinical Trials
Common Rule Updates Tips and Tricks
Central IRB Components of ARCADIA
Environmental Cleaning Tool Kit
Presentation transcript:

Streamlined Data Collection Emmanuelle Denis CREDO Workshop 1 UVRI, Entebbe, Uganda 9 March, 2017

Data: management, harmonisation and sharing module Intended Learning Objectives At the end of the module participants will be able to: Explain the important role of data harmonisation and sharing in outbreak research Describe the elements of a data management plan Identify outbreak research platforms for sharing and developing protocols and data capture tools There is a module of CREDO that covers data management, harmonisation and sharing of clinical research data.

Streamlined data collection Intended Learning Objectives To understand the benefits of streamlined data collection To be able to plan efficient data collection for a study This short talk will focus on ways to streamline data collection for a study and reduce the gathering of extraneous or unnecessary data

Keep it simple For every question, measurement or test ask: What am I collecting this information for? Avoid collecting extraneous (‘just in case’) data - remember that all data collected will need to be entered and cleaned Collect only the data variables that are required by the protocol and needed for your database The ultimate goal is to ensure that the information generated from the data can answer the research question

Plan ahead Case report form (CRF) development should be done concurrently with protocol development Allow plenty of time for revisions and for validation and testing if you are going to use an electronic CRF

Don’t reinvent the wheel If you have run other clinical research studies in your institute you can probably adapt their CRFs – particularly for ‘standard’ modules like demographics or adverse events ISARIC has freely available Severe Acute Respiratory Infection and Viral Haemorrhagic Fever Data Tools https://isaric.tghn.org/protocols/

Reasons for data collection Why? When? Who? Eligibility Screening Everyone Identify subgroups Randomization Safety Every follow-up Everyone (not just those on treatment) Compliance measures Particular times during follow-up Random sample or everyone? Outcomes Other outcome measures Final follow-up Random sample or everyone So the important questions to ask are: why am I collecting this data, when do I need to collect it? and on whom do I need to collect it? I borrowed this slide from a colleague who works in Oxford’s Clinical Trial Service Unit (CTSU). CTSU specialises in ‘mega-trials’ of cancer and cardiovascular disease that enrol thousands of patients so the last question is of particular importance to them since some questions may be answered by collecting data on only a random sample of participants . In a smaller trial of an infectious disease you will probably need to collect all data on all participants Table courtesy of Dr Marion Mafham, Senior Clinical Research Fellow, CTSU, University of Oxford

Recommendations for CRF design Necessary Data Only Design the CRF along with protocol to assure collection of only these data the protocol specifies. CRFs should avoid collecting redundant data and should instead focus on collecting only the data needed to answer the protocol questions and to provide adequate safety and efficacy data Minimise the collection of data as ‘free text’

Recommendations for CRF design Keep questions, prompts and instructions clear and concise. Design the CRF to follow the data flow from the perspective of the person completing it, taking into account the flow of study procedures

Recommendations for CRF design Avoid recording calculated data Example: Body mass index –> record weight and height X 

Recommendations for CRF design Avoid recording calculated data Example: Dates Time Point Date Calculation Baseline 16-Oct-2017 =baseline Day 1 17-Oct-2017 =baseline+1 Day 3 19-Oct-2017 =baseline+3 Day 7 23-Oct-2017 =baseline+7 Day 14 30-Oct-2017 =baseline+14

Recommendations for CRF design Avoid redundant data points within the CRF whenever possible. -> i.e. don’t collect the same information twice!

Recommendations for CRF design Document the process for CRF design, development, approval and version control. Make the CRF available at the clinical site prior to enrolment of a subject. Document training of clinical site personnel on the protocol, CRF completion instructions and data submission procedures prior to enrolment of a subject.